Atlas Trials

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

Clinical trial NCT02929251 · COMPLETED

Trial details

NCT number
NCT02929251
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
UveitisBiotherapy
Start date
2017-06-29
Primary completion
2021-10-29
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.